{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:24:09Z","timestamp":1787257449465,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jbc.2026.113302","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:02:54Z","timestamp":1782774174000},"page":"113302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression"],"prefix":"10.1016","volume":"302","author":[{"given":"Katerina-Marina","family":"Pilala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artemis-Melina","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Alexandra","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Panoutsopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios-Christos","family":"Giagkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-0237","authenticated-orcid":false,"given":"Panagiotis","family":"Levis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Kanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dido","family":"Vassilacopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Stravodimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-861X","authenticated-orcid":false,"given":"Apostolos","family":"Klinakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Scorilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-9886","authenticated-orcid":false,"given":"Margaritis","family":"Avgeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.113302_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2026.113302_bib2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2026.113302_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskjot","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jbc.2026.113302_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","article-title":"Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective","volume":"19","author":"Teoh","year":"2022","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jbc.2026.113302_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","article-title":"European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines","volume":"85","author":"Alfred Witjes","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jbc.2026.113302_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2026.113302_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34114","article-title":"Global burden of bladder cancer attributable to smoking in 204 countries and territories, 1990-2019","volume":"10","author":"Yuan","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jbc.2026.113302_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111859","article-title":"Genomic heterogeneity as a barrier to precision oncology in urothelial cancer","volume":"41","author":"Clinton","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.113302_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.euf.2018.11.005","article-title":"Risk stratification tools and prognostic models in non-muscle-invasive bladder cancer: a critical assessment from the European Association of Urology non-muscle-invasive bladder cancer guidelines panel","volume":"6","author":"Soukup","year":"2020","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.jbc.2026.113302_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11934-018-0860-6","article-title":"Bladder cancer survivorship","volume":"19","author":"Bhanvadia","year":"2018","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.jbc.2026.113302_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","article-title":"Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice","volume":"20","author":"van Hoogstraten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.113302_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eururo.2025.03.017","article-title":"Bladder preservation strategies in muscle-invasive bladder cancer: recommendations from the International Bladder Cancer Group","volume":"89","author":"Gupta","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jbc.2026.113302_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41585-024-00914-7","article-title":"Molecular biomarkers of progression in non-muscle-invasive bladder cancer - beyond conventional risk stratification","volume":"22","author":"Olislagers","year":"2025","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jbc.2026.113302_bib14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jbc.2026.113302_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1735","article-title":"Epi-miRNAs: modern mediators of methylation status in human cancers","volume":"14","author":"Papadimitriou","year":"2023","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.jbc.2026.113302_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110354","article-title":"Functional mechanism and clinical implications of miR-141 in human cancers","volume":"95","author":"Luo","year":"2022","journal-title":"Cell Signal."},{"key":"10.1016\/j.jbc.2026.113302_bib17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2018.12.089","article-title":"MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer","volume":"509","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2026.113302_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5425491","article-title":"The mechanism of miR-141 regulating the proliferation and metastasis of liver cancer cells by targeting STAT4","volume":"2021","author":"Ma","year":"2021","journal-title":"J. Oncol."},{"key":"10.1016\/j.jbc.2026.113302_bib19","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1007\/s12094-021-02653-2","article-title":"Study on effects of miR-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl2","volume":"23","author":"Tong","year":"2021","journal-title":"Clin. Transl Oncol."},{"key":"10.1016\/j.jbc.2026.113302_bib20","article-title":"MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113302_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s13046-019-1470-y","article-title":"Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K\/Akt signaling pathway","volume":"38","author":"Xu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.113302_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2020.07.040","article-title":"Targeting the radiation-induced TR4 nuclear receptor-mediated QKI\/circZEB1\/miR-141-3p\/ZEB1 signaling increases prostate cancer radiosensitivity","volume":"495","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.113302_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.canlet.2018.01.036","article-title":"Long non-coding RNA XIST promotes TGF-beta-induced epithelial-mesenchymal transition by regulating miR-367\/141-ZEB2 axis in non-small-cell lung cancer","volume":"418","author":"Li","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2026.113302_bib24","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/pros.23201","article-title":"Regulation of miR-200c and miR-141 by methylation in prostate cancer","volume":"76","author":"Lynch","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.jbc.2026.113302_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147611","article-title":"miR-141-3p inhibits the activation of astrocytes and the release of inflammatory cytokines in bacterial meningitis through down-regulating HMGB1","volume":"1770","author":"Fang","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.jbc.2026.113302_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.jbc.2026.113302_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41585-020-0304-1","article-title":"Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes","volume":"17","author":"Meeks","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jbc.2026.113302_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jbc.2026.113302_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.euo.2019.01.015","article-title":"The cost to medicare of bladder cancer care","volume":"3","author":"Sloan","year":"2020","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.jbc.2026.113302_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Consortium","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.113302_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrm3611","article-title":"Diversifying microRNA sequence and function","volume":"14","author":"Ameres","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113302_bib32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nrurol.2013.113","article-title":"Aberrant expression of microRNAs in bladder cancer","volume":"10","author":"Yoshino","year":"2013","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jbc.2026.113302_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41576-024-00760-8","article-title":"DNA methylation in mammalian development and disease","volume":"26","author":"Smith","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jbc.2026.113302_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ymthe.2024.12.003","article-title":"Exploring the methyl-verse: dynamic interplay of epigenome and m6A epitranscriptome","volume":"33","author":"Pilala","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbc.2026.113302_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.113302_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.gene.2016.07.047","article-title":"Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma","volume":"593","author":"Shen","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.jbc.2026.113302_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/345080","article-title":"Hypermethylation-Associated silencing of miR-125a and miR-125b: a potential marker in colorectal cancer","volume":"2015","author":"Chen","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jbc.2026.113302_bib38","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s41374-018-0092-x","article-title":"miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation","volume":"98","author":"Zhang","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jbc.2026.113302_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.omtn.2022.10.001","article-title":"Epigenetic regulation of MIR145 core promoter controls miR-143\/145 cluster in bladder cancer progression and treatment outcome","volume":"30","author":"Pilala","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jbc.2026.113302_bib40","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1038\/onc.2016.22","article-title":"Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells","volume":"35","author":"Lopez-Bertoni","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113302_bib41","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2217\/fon-2018-0155","article-title":"Roles of miR-200 family members in lung cancer: more than tumor suppressors","volume":"14","author":"Liu","year":"2018","journal-title":"Future Oncol."},{"key":"10.1016\/j.jbc.2026.113302_bib42","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/ijc.31282","article-title":"The role of the miR-200 family in epithelial-mesenchymal transition in colorectal cancer: a systematic review","volume":"142","author":"O'Brien","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2026.113302_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1756-0500-3-219","article-title":"Role of DNA methylation in miR-200c\/141 cluster silencing in invasive breast cancer cells","volume":"3","author":"Neves","year":"2010","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.jbc.2026.113302_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12032-023-02099-2","article-title":"Novel insights on perils and promises of miRNA in understanding colon cancer metastasis and progression","volume":"40","author":"Tariq","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jbc.2026.113302_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411861","article-title":"Interactions between circRNAs and miR-141 in cancer: from pathogenesis to diagnosis and therapy","volume":"24","author":"Guz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.113302_bib46","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S1470-2045(21)00343-0","article-title":"Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer","volume":"22","author":"Zhang","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbc.2026.113302_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13045-024-01634-6","article-title":"Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition","volume":"18","author":"Glaviano","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jbc.2026.113302_bib48","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/biomedicines11051364","article-title":"Zinc finger E-Box binding homeobox family: non-coding RNA and epigenetic regulation in gliomas","volume":"11","author":"Lenda","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbc.2026.113302_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41419-019-1339-1","article-title":"lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial-mesenchymal transition by competitively binding miR-141-3p","volume":"10","author":"Qian","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2026.113302_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.omtn.2019.11.003","article-title":"LncRNA MAGI2-AS3 is regulated by BRD4 and promotes gastric cancer progression via maintaining ZEB1 overexpression by sponging miR-141\/200a","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jbc.2026.113302_bib51","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/jcmm.14767","article-title":"An EMT-related gene signature for the prognosis of human bladder cancer","volume":"24","author":"Cao","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.jbc.2026.113302_bib52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41392-024-01938-6","article-title":"Circulating tumor cells: from new biological insights to clinical practice","volume":"9","author":"Gu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2026.113302_bib53","article-title":"Influence of epithelial-mesenchymal transition on risk of relapse and outcome to eribulin or cyclin-dependent kinase inhibitors in metastatic breast cancer","volume":"8","author":"Chan","year":"2024","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.jbc.2026.113302_bib54","article-title":"Clinicopathological significance of Kruppel-like factor 15 and epithelial-to-mesenchymal transition related factors in bladder cancer","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.113302_bib55","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1038\/s41388-025-03624-5","article-title":"From concept to clinic: a roadmap for DNA methylation biomarkers in liquid biopsies","volume":"44","author":"Pharo","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113302_bib56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4939-8751-1_17","article-title":"Pyrosequencing methylation analysis","volume":"1856","author":"Poulin","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbc.2026.113302_bib57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13072-017-0123-7","article-title":"Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA","volume":"10","author":"Skvortsova","year":"2017","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.jbc.2026.113302_bib58","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1038\/s41467-022-32915-8","article-title":"Vitamin C epigenetically controls osteogenesis and bone mineralization","volume":"13","author":"Thaler","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113302_bib59","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1158\/0008-5472.CAN-11-2023","article-title":"5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations","volume":"71","author":"Jin","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.113302_bib60","doi-asserted-by":"crossref","first-page":"627","DOI":"10.18632\/oncotarget.316","article-title":"Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem\/progenitor cell compartments and in human cancers","volume":"2","author":"Haffner","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.113302_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146302","article-title":"Global 5-Hydroxymethylcytosine levels are profoundly reduced in multiple genitourinary malignancies","volume":"11","author":"Munari","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.113302_bib62","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3390\/cancers13102446","article-title":"Generation of non-small cell lung cancer patient-derived xenografts to study intratumor heterogeneity","volume":"13","author":"Kanaki","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.113302_bib63","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846821","article-title":"Lysine-specific methyltransferase KMT2C\/MLL3 regulates DNA repair components in cancer","volume":"20","author":"Rampias","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jbc.2026.113302_bib64","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jbc.2026.113302_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav1741","article-title":"The biochemical basis of microRNA targeting efficacy","volume":"366","author":"McGeary","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.113302_bib66","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.113302_bib67","doi-asserted-by":"crossref","first-page":"D870","DOI":"10.1093\/nar\/gkac947","article-title":"CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data","volume":"51","author":"Hu","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.113302_bib68","article-title":"Appyters: turning Jupyter notebooks into data-driven web apps","volume":"2","author":"Clarke","year":"2021","journal-title":"Patterns (N Y)"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826021745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826021745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T19:38:26Z","timestamp":1787254706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826021745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0021925826021745"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113302","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"113302"}}